143 related articles for article (PubMed ID: 6603085)
1. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
[TBL] [Abstract][Full Text] [Related]
2. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
[TBL] [Abstract][Full Text] [Related]
3. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of ventricular tachycardia in infancy and childhood with amiodarone].
Batisse A; Sardet A; Fermont L; Kachaner J
Arch Mal Coeur Vaiss; 1982 Aug; 75(8):829-35. PubMed ID: 6814383
[TBL] [Abstract][Full Text] [Related]
5. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
8. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone in refractory life-threatening ventricular arrhythmias.
Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
[TBL] [Abstract][Full Text] [Related]
10. Use of amiodarone in the therapy of primary ventricular arrhythmias in children.
Pickoff AS; Singh S; Flinn CJ; Wolff GS; Gelband H
Dev Pharmacol Ther; 1983; 6(2):73-82. PubMed ID: 6861598
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
Chiale PA; Halpern MS; Nau GJ; Tambussi AM; Przybylski J; Lázzari JO; Elizari MV; Rosenbaum MB
Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
Veltri EP; Reid PR; Platia EV; Griffith LS
J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone: correlation of serum concentration with suppression of complex ventricular ectopic activity.
Mostow ND; Rakita L; Vrobel TR; Noon DL; Blumer J
Am J Cardiol; 1984 Sep; 54(6):569-74. PubMed ID: 6475775
[TBL] [Abstract][Full Text] [Related]
16. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
[TBL] [Abstract][Full Text] [Related]
17. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
Kaski JC; Girotti LA; Elizari MV; Lázzari JO; Goldbarg A; Tambussi A; Rosenbaum MB
Am Heart J; 1984 Apr; 107(4):648-55. PubMed ID: 6702558
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
Nademanee K; Singh BN; Hendrickson JA; Reed AW; Melmed S; Hershman J
Circulation; 1982 Jul; 66(1):202-11. PubMed ID: 7083508
[TBL] [Abstract][Full Text] [Related]
20. [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone].
Cassagneau B; Calazel J; Puel J; Massabuau P; Tournadre P; Fauvel JM; Bounhoure JP; Marin T; Narula OS
Arch Mal Coeur Vaiss; 1984 Jul; 77(7):766-72. PubMed ID: 6433839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
